(Q34334116)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512440%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

title

Ascending dose-controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512440%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

0 references

Jonathan P. Whitehead

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512440%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

T E Hughes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512440%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

D D Kim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512440%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

J Marjason

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512440%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

J Proietto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512440%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

J E Vath

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512440%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

25 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512440%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512440%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512440%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512440%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

1782-1788

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512440%20AND%20SRC:MED&resulttype=core&format=json

Prevalence and trends in obesity among US adults, 1999-2008

26 February 2020

cites work

1 reference

Long-term persistence of hormonal adaptations to weight loss

21 January 2018

1 reference

Relation of health-related quality of life to metabolic syndrome, obesity, depression and comorbid illnesses

21 January 2018

1 reference

Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP)

21 January 2018

1 reference

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

21 January 2018

1 reference

Multicenter, placebo-controlled trial of lorcaserin for weight management

21 January 2018

1 reference

Valvular heart disease associated with fenfluramine-phentermine

21 January 2018

1 reference

Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest

21 January 2018

1 reference

Adipose tissue mass can be regulated through the vasculature

21 January 2018

1 reference

Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice

21 January 2018

1 reference

Assessment of the anti-obesity effects of the TNP-470 analog, CKD-732.

21 January 2018

1 reference

Fumagillin reduces adipose tissue formation in murine models of nutritionally induced obesity

21 January 2018

1 reference

The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2

21 January 2018

1 reference

Novel inhibitors targeted to methionine aminopeptidase 2 (MetAP2) strongly inhibit the growth of cancers in xenografted nude model

21 January 2018

1 reference

A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer.

21 January 2018

1 reference

Treatment of cells with the angiogenic inhibitor fumagillin results in increased stability of eukaryotic initiation factor 2-associated glycoprotein, p67, and reduced phosphorylation of extracellular signal-regulated kinases

21 January 2018

1 reference

Phosphorylation of sterol regulatory element-binding protein (SREBP)-1a links growth hormone action to lipid metabolism in hepatocytes.

21 January 2018

1 reference

SREBPs: the crossroads of physiological and pathological lipid homeostasis

21 January 2018

1 reference

Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies.

21 January 2018

1 reference

Short-term medical benefits and adverse effects of weight loss

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/OBY.20356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512440%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference